For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety
For scalp protocols, it is applied to the scalp only, usually in the areas where thinning or shedding is being addressed
Overview [edit] Several copper(II)-peptide complexes occur naturally
Dr Jill Hi Dr Jill, I was recently tested and in compound heterozygous
We propose that Lurcher mice suffering from early-onset olivocerebellar degeneration can be considered as a model to study the mechanisms of the components of both cerebellar motor syndrome and CCAS, with the limitation to analogous conditions (e.g., whole cerebellum affection, early loss of Purkinje cells) and of course with all the limitations of murine models of human diseases [254, 255]
[DOI] [PMC free article] [PubMed] [Google Scholar] 139.Tu Z., Anders M.W